| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |